| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.2 | 5e-06 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.26 | 7e-06 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.29 | 0.0001 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.29 | 0.0002 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |